Cargando…
Current Approaches and Tools Used in Drug Development against Parkinson’s Disease
Parkinson’s disease is a progressive neurodegenerative disorder characterized by the death of nerve cells in the substantia nigra of the brain. The treatment options for this disease are very limited as currently the treatment is mainly symptomatic, and the available drugs are not able to completely...
Autores principales: | Koszła, Oliwia, Stępnicki, Piotr, Zięba, Agata, Grudzińska, Angelika, Matosiuk, Dariusz, Kaczor, Agnieszka A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235487/ https://www.ncbi.nlm.nih.gov/pubmed/34208760 http://dx.doi.org/10.3390/biom11060897 |
Ejemplares similares
-
Overcoming Depression with 5-HT(2A) Receptor Ligands
por: Zięba, Agata, et al.
Publicado: (2021) -
Screening and Structure–Activity Relationship of D2AAK1 Derivatives for Potential Application in the Treatment of Neurodegenerative Diseases
por: Koszła, Oliwia, et al.
Publicado: (2022) -
The Role of Genetics in the Development and Pharmacotherapy of Depression and Its Impact on Drug Discovery
por: Zięba, Agata, et al.
Publicado: (2023) -
The Antipsychotic D2AAK1 as a Memory Enhancer for Treatment of Mental and Neurodegenerative Diseases
por: Koszła, Oliwia, et al.
Publicado: (2020) -
Multi-Target Approach for Drug Discovery against Schizophrenia
por: Kondej, Magda, et al.
Publicado: (2018)